Notice: Prescription Drug List (PDL): Multiple Additions (2021-09-10)

The purpose of this Notice of Amendment is to notify about the additions of: Elexacaftor, Inclisiran, Ospemifene, Pralsetinib and Tafasitamab to the Prescription Drug List (PDL) for human and veterinary use, and Frunevetmab to the PDL for veterinary use.

Data and Resources

Additional Info

Field Value
Last Updated April 17, 2026, 22:01 (UTC)
Created April 17, 2026, 22:01 (UTC)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2021-09-07 00:00:00
open_canada_keywords {"fr": ["avis de modification", "Liste des drogues sur ordonnance", "PDL", "Elexacaftor", "Inclisiran", "Ospemifene", "Pralsetinib", "Tafasitamab", "PDL pour usage humain et vétérinaire", "Frunevetmab", "PDL pour usage vétérinaire"], "en": ["notice of amendment", "Prescription Drug List", "PDL", "Elexacaftor", "Inclisiran", "Ospemifene", "Pralsetinib", "Tafasitamab", "PDL for human-and-veterinary use", "Frunevetmab", "PDL for veterinary-use"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Avis : Liste des drogues sur ordonnance (LDO) : additions multiples
update_frequency as_needed